, Tracking Stock Market Picks
Enter Symbol:
Synta Pharmaceuticals Corp. (SNTA) [hlAlert]

down 32.42 %

Synta Pharmaceuticals Corp. (SNTA) rated Buy with price target $6 by Morgan Joseph

Posted on: Thursday,  Aug 26, 2010  9:25 AM ET by Morgan Joseph

Morgan Joseph rated Buy Synta Pharmaceuticals Corp. (NASDAQ: SNTA) on 08/26/2010, when the stock price was $2.93. Since
then, Synta Pharmaceuticals Corp. has lost 32.42% as of 01/27/2016's recent price of $1.98.
If you would have followed this Morgan Joseph's recommendation on SNTA, you would have lost 32.42% of your investment in 1980 days.

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. The Company has three clinical-stage drug candidates and several drug candidates in the preclinical and discovery stages. In December 2008, the Company entered into a partnership with Hoffmann-La Roche for its CRACM inhibitor program. The Company?s drug candidates include Elesclomol, STA-9090, STA-9584, Apilimod (STA-5326), Oral CRACM channel inhibitor and CRAC channel inhibitor. The Company has two clinical-stage programs and one preclinical-stage program in oncology.

Morgan Joseph is committed to providing timely, objective and actionable investment advice on the companies and securities we follow. Our team of equity analysts covers a growing universe of stock issues across a broad range of industry sectors. As a middle market-focused firm, our approach is not to publish research on as many companies as possible within a number of industry sectors. Rather, our research analysts distinguish themselves by zeroing in on quality companies with growth prospects or which present special situations. These companies often lack a research following. This enables our analysts to provide insight to investors in companies that are not well understood nor fairly valued.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/26/2010 9:25 AM Buy
2.93 6.00
as of 12/31/2010
1 Week down  -22.23 %
1 Month up  14.91 %
3 Months up  23.55 %
1 YTD up  68.25 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy